Characteristics of human T-lymphotropic virus type-1 (HTLV-1)-infected cell line MT-2, which is not killed by a natural killer cell line NK-92 but iskilled by lymphokine-activated killer cells
F. Komatsu et S. Yoshida, Characteristics of human T-lymphotropic virus type-1 (HTLV-1)-infected cell line MT-2, which is not killed by a natural killer cell line NK-92 but iskilled by lymphokine-activated killer cells, ONCOL RES, 11(5), 1999, pp. 213-218
Natural killer (NK) cell-mediated cytolysis (NK-lysis) is triggered by cost
imulatory signals of adhesion molecules and is downregulated by negative si
gnals of killer cell inhibitory receptors (KIRs). Recently, a NK cell line,
NK-92, was established. This cell line can kill several tumor cells, which
possess adhesion molecules CD54 and CD102. However, the NK-92 cannot kill
a human T-lymphotropic virus type 1 (HTLV-l)-infected cell line, MT-2, alth
ough lymphokine-activated killer (LAK) cells can kill MT-2. In this report
we investigated the reason for LAK sensitivity but NK-92 resistance of the
MT-2. The MT-2 highly expressed CD54 and CD102, suggesting that the costimu
latory signals may be intact. Then we tested the responsibility of the nega
tive signals by determining HLA type of the MT-2 and KIRs of the effector c
ells. The MT-2 expressed HLA-A24, B40, B51, Cw3, and HLA-G. The NK-92 did n
ot express KIR2DL1, KIR2DL2,3, nor KIR3DL1, but 24% of the cells weakly exp
ressed CD94. The blocking tests against these HLA class I molecules and Kms
did not restore the NK-92 resistance, although blocking against HLA-G slig
htly increased its lysis. Finally, in order to eliminate the class I molecu
les from the cell surface, we treated the MT-2 using a buffered citric acid
solution (pH 3.8). By using this treatment, the expression of class I mole
cules and HTLV-1 antigen decreased, and then the MT-2 was killed by the NK-
92. These findings suggest that an aberrant class I molecule of the MT-2 tr
ansferred a negative signal to the NK-92 and induced the NK-92 resistance.
rt remains to be elucidated whether or not the HTLV-l infection contributed
to the alteration of the class I molecule.